Informing rational design of graphene oxide through surface chemistry manipulations: properties governing electrochemical and biological activities

2017 ◽  
Vol 19 (12) ◽  
pp. 2826-2838 ◽  
Author(s):  
Yan Wang ◽  
Leanne M. Gilbertson

The electrochemical and biological activities are synergistically driven by the physicochemical properties of graphene oxide and reduced graphene oxide.

2021 ◽  
Author(s):  
R Rajalakshmi ◽  
Remya K. P. ◽  
Viswanathan Chinnuswamy ◽  
Nagamony Ponpandian

The morphology of a nanoparticle strongly controls the path ofelectronic interaction, which directly correlates to the physicochemical properties and also the electrochemical comportment. Conjoining it with a two-dimensional (2D) material...


RSC Advances ◽  
2016 ◽  
Vol 6 (49) ◽  
pp. 43697-43706 ◽  
Author(s):  
Can Cui ◽  
Yiwei Qiu ◽  
Haihua Hu ◽  
Ni Ma ◽  
Shuang Li ◽  
...  

Rational design of a novel Ag3PO4/TiO2/Ag-rGO photocatalyst with both electron and hole pathways for charge separation.


2017 ◽  
Vol 5 (24) ◽  
pp. 12426-12434 ◽  
Author(s):  
Junghoon Yang ◽  
Jeongyim Shin ◽  
Mihui Park ◽  
Gi-Hyeok Lee ◽  
Mawuse Amedzo-Adore ◽  
...  

This work studied the synergistic effect of N-doping and p-PDA functionalization on the properties of RGO for supercapacitors.


Nanoscale ◽  
2018 ◽  
Vol 10 (36) ◽  
pp. 17092-17098 ◽  
Author(s):  
Junpeng Xie ◽  
Yongqian Zhu ◽  
Ning Zhuang ◽  
Hang Lei ◽  
Weiling Zhu ◽  
...  

We are the first to utilize reduced graphene oxide (RGO) wrapped metal organic framework-derived FeS2 hollow nanocages (FeS2@RGO) as an anode for K-ion batteries.


2020 ◽  
Vol 35 (4-5) ◽  
pp. 363-377
Author(s):  
Negar Karimi Hajishoreh ◽  
Nafiseh Baheiraei ◽  
Nasim Naderi ◽  
Mojdeh Salehnia

The benefits of combined cell/material therapy appear promising for myocardial infarction treatment. The safety of alginate, along with its excellent biocompatibility and biodegradability, has been extensively investigated for cardiac tissue engineering. Among graphene-based nanomaterials, reduced graphene oxide has been considered as a promising candidate for cardiac treatment due to its unique physicochemical properties. In this study, the reduced graphene oxide incorporation effect within alginate hydrogels was investigated for cardiac repair application. Reduced graphene oxide reinforced alginate properties, resulting in an increase in gel stiffness. The cytocompatibility of the hydrogels prepared with human bone marrow–derived mesenchymal stem cells was assessed by the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide) assay. Following reduced graphene oxide addition, alginate-reduced graphene oxide retained significantly higher cell viability compared to that of alginate and cells cultured on tissue culture plates. Acridine orange/propidium iodide staining was also used to identify both viable and necrotic human bone marrow–derived mesenchymal stem cells within the prepared hydrogels. After a 72-h culture, the percentage of viable cells was twice as much as those cultured on either alginate or tissue culture plate, reaching approximately 80%. Quantitative reverse transcription polymerase chain reaction analysis was performed to assess gene expression of neonatal rat cardiac cells encapsulated on hydrogels for TrpT-2, Conx43, and Actn4 after 7 days. The expression of all genes in alginate-reduced graphene oxide increased significantly compared to that in alginate or tissue culture plate. The results obtained confirmed that the presence of reduced graphene oxide, as an electro-active moiety within alginate, could tune the physicochemical properties of this material, providing a desirable electroactive hydrogel for stem cell therapy in patients with ischemic heart disease.


Sign in / Sign up

Export Citation Format

Share Document